普洛药业涨2.01%，成交额1.35亿元，主力资金净流入953.05万元

Core Viewpoint - Prolo Pharmaceutical's stock has shown fluctuations in price and trading volume, with a recent increase of 2.01% and a total market capitalization of 18.79 billion yuan [1] Financial Performance - For the first half of 2025, Prolo Pharmaceutical reported a revenue of 5.444 billion yuan, a year-on-year decrease of 15.31%, and a net profit attributable to shareholders of 563 million yuan, down 9.89% year-on-year [2] - The company has cumulatively distributed 2.472 billion yuan in dividends since its A-share listing, with 1.129 billion yuan distributed over the last three years [3] Shareholder Information - As of June 30, 2025, Prolo Pharmaceutical had 51,400 shareholders, a decrease of 0.52% from the previous period, with an average of 22,508 circulating shares per shareholder, down 0.41% [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which holds 29.8493 million shares, a decrease of 2.0211 million shares from the previous period [3]